An inverse relationship exists between these proteins; mutations or defects in p53 along with constitutively active NF-κB levels in several human cancers including prostate malignancy lead to increased proliferation and suppression of apoptosis [21,22,23]. The gene discussed is TP53; the disease is cancer.